Trial NCT04324021

View at ClinicalTrials.gov 
Org. Study IDs: Sobi.IMMUNO-101
Secondary IDs: 2020-001167-93

Last trial update was posted on 2022-03-10

MeSH Interventions

Interleukin 1 Receptor Antagonist Protein

MeSH Conditions

Infections

Other Conditions

SARS-CoV-2

Stopping Reasons

Standard of care evolved during the timeframe of the study and had critical impact on recruitment. Early termination was not based on safety reasons but due to the reasons mentoined above. The ongoing patients were completed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID